Skip to content
The Policy VaultThe Policy Vault

DibenzylineMedica

pheochromocytoma

Preferred products

  • phenoxybenzamine (generic)

Initial criteria

  • Patient has diagnosis of pheochromocytoma
  • If brand Dibenzyline is requested, patient has tried generic phenoxybenzamine AND cannot continue to use generic phenoxybenzamine due to a formulation difference in inactive ingredients that would result in a significant allergy or a serious adverse reaction [documentation required]
  • Medication is prescribed by or in consultation with an endocrinologist or a physician who specializes in the management of pheochromocytoma

Approval duration

1 year